Category: Include on Menu

Tecnoglass (NYSE:TGLS) fell 8.5% Thursday following a report from Culper Research claiming that the company’s CEO and COO have links to Colombia’s Sinaloa cartel. The report asserts that leaked Mexican intelligence documents identify Jose and Christian Daes as involved in financial schemes tied to the cartel. Culper Research also alleges that the cartel used Banco…

Rent the Runway (NASDAQ:RENT) surged 20% after unveiling a major growth recapitalization aimed at reducing debt and fueling expansion. Under the plan, Aranda Principal Strategies (APS) will convert approximately $243 million of debt into common equity at $9.23 per share, marking an 80.9% premium to the recent 30-day average price of $5.10. The recapitalization also…

Dynavax Technologies Corporation (NASDAQ:DVAX) surged 8% Thursday following the announcement of encouraging topline data from its Phase 1/2 trial of Z-1018, the company’s experimental shingles vaccine. The trial showed that Z-1018 produced immune responses comparable to GlaxoSmithKline (NYSE:GSK)’s Shingrix, the leading shingles vaccine, while offering a notably improved tolerability profile. At the selected dose, Z-1018…

OSI Systems, Inc. (NASDAQ:OSIS) saw its stock climb 2.96% in pre-market trading Thursday after reporting fourth-quarter results and issuing a bullish fiscal 2026 outlook. For the quarter, the security and healthcare technology company posted adjusted earnings of $3.24 per share, up 14% year-over-year, slightly below analysts’ estimate of $3.19. Revenue reached a record $504.99 million,…

ScanSource, Inc. (NASDAQ:SCSC) saw its stock rise 3.36% in pre-market trading Thursday after reporting fourth-quarter results that exceeded analyst expectations and providing a positive outlook for fiscal 2026. For the quarter ended June 30, 2025, the Greenville, South Carolina-based technology distributor posted adjusted earnings of $1.02 per share, above the consensus of $0.93. Revenue reached…

Gilead Sciences (NASDAQ:GILD) saw its stock decline 2.7% in pre-market trading Thursday following news that CVS Health (NYSE:CVS) will not immediately add the company’s new HIV prevention drug, Yeztugo, to its commercial plans. CVS, the largest U.S. pharmacy benefit manager, cited clinical, financial, and regulatory considerations for the decision. The drug will also not be…

Sarepta Therapeutics (NASDAQ:SRPT) saw its stock fall 3.3% in pre-market trading Thursday following the announcement of a refinancing of roughly $700 million of its 1.25% Convertible Senior Notes due 2027. The precision genetic medicine company reached exchange agreements with select holders of the existing notes. Under these agreements, Sarepta will swap the notes for approximately…

Navios Maritime Partners L.P. (NYSE:NMM) saw its shares rise nearly 5% in pre-market trading Thursday after reporting second-quarter revenue that topped analyst forecasts, reflecting continued strength in global shipping demand despite geopolitical headwinds. The company posted $327.6 million in revenue for Q2, above the consensus estimate of $305.29 million. Adjusted earnings per unit came in…

Shares of The Marzetti Company (NASDAQ:MZTI) declined 3% Thursday after the specialty foods manufacturer reported fourth-quarter results that fell short of analyst earnings expectations, despite posting record revenue. For the fiscal fourth quarter ended June 30, 2025, the company reported earnings of $1.18 per diluted share, below the anticipated $1.34. Revenue climbed 5% year-over-year to…

SelectQuote, Inc. (NYSE:SLQT) exceeded analyst expectations in its fourth-quarter fiscal 2025 results, reporting revenue of $345.1 million, up 12.3% year-over-year, versus the consensus forecast of $343.94 million. The company posted a quarterly loss of just $0.02 per share, far better than the predicted -$0.16 per share. Following the earnings release, SelectQuote shares rose 1.09% in…